Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis
- PMID: 24652582
- PMCID: PMC4127154
- DOI: 10.1007/s00455-014-9522-0
Swallowing outcomes following unilateral STN vs. GPi surgery: a retrospective analysis
Abstract
The adverse effects of deep brain stimulation (DBS) surgery on swallowing could potentially exacerbate the natural deterioration of airway protection associated with Parkinson's disease (PD) degeneration and increase the incidence of aspiration pneumonia and associated death. There are no studies that compare swallowing outcomes associated with subthalamic nucleus (STN) versus globus pallidus interna (GPi) DBS surgery; therefore, we completed a retrospective study comparing swallowing outcomes in a cohort of patients with PD who underwent unilateral DBS surgery in either the STN or GPi. A chart review was completed to identify all patients with a diagnosis of PD who received videofluoroscopic swallowing evaluations before DBS and after unilateral DBS in the STN or GPi. The retrospective search yielded 33 patients (STN = 14, GPi = 19) with idiopathic PD who met the inclusion criteria. Mean penetration-aspiration (PA) scores did not change significantly for participants who underwent GPi surgery (z = -.181, p = .857), but mean PA scores significantly worsened for participants who underwent STN DBS (z = -2.682, p = .007). There was a significant improvement in Unified PD Rating Scale (UPDRS) scores off medication before surgery, to off medication and on stimulation after surgery for both groups (F = 23.667, p < .001). Despite the limitations of a retrospective analysis, this preliminary study suggests that unilateral STN DBS may have an adverse effect on swallowing function, while unilateral GPi DBS does not appear to have a similar deleterious effect. This study and other future studies should help to elucidate the mechanisms underpinning the effects of DBS on swallowing function.
Figures

Similar articles
-
Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.J Neurosurg. 2014 Sep;121(3):709-18. doi: 10.3171/2014.4.JNS131711. Epub 2014 Jun 6. J Neurosurg. 2014. PMID: 24905564
-
Brain penetration effects of microelectrodes and DBS leads in STN or GPi.J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):794-7. doi: 10.1136/jnnp.2008.159558. Epub 2009 Feb 22. J Neurol Neurosurg Psychiatry. 2009. PMID: 19237386 Free PMC article. Clinical Trial.
-
Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.Arch Neurol. 2005 Apr;62(4):554-60. doi: 10.1001/archneur.62.4.554. Arch Neurol. 2005. PMID: 15824252 Clinical Trial.
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.Neurosurgery. 2018 Jun 1;82(6):753-756. doi: 10.1093/neuros/nyy037. Neurosurgery. 2018. PMID: 29538685 Free PMC article.
-
Swallowing and deep brain stimulation in Parkinson's disease: a systematic review.Parkinsonism Relat Disord. 2013 Sep;19(9):783-8. doi: 10.1016/j.parkreldis.2013.05.001. Epub 2013 May 28. Parkinsonism Relat Disord. 2013. PMID: 23726461 Free PMC article.
Cited by
-
Tailored deep brain stimulation optimization for improved airway protective outcomes in Parkinson's disease.Interdiscip Neurosurg. 2016 Sep;5:3-5. doi: 10.1016/j.inat.2016.03.003. Interdiscip Neurosurg. 2016. PMID: 27795943 Free PMC article.
-
Gut dysfunction in Parkinson's disease.World J Gastroenterol. 2016 Jul 7;22(25):5742-52. doi: 10.3748/wjg.v22.i25.5742. World J Gastroenterol. 2016. PMID: 27433087 Free PMC article. Review.
-
Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease.J Parkinsons Dis. 2016;6(1):197-208. doi: 10.3233/JPD-150687. J Parkinsons Dis. 2016. PMID: 26891176 Free PMC article.
-
A comprehensive review of the diagnosis and treatment of Parkinson's disease dysphagia and aspiration.Expert Rev Gastroenterol Hepatol. 2020 Jun;14(6):411-424. doi: 10.1080/17474124.2020.1769475. Expert Rev Gastroenterol Hepatol. 2020. PMID: 32657208 Free PMC article.
-
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.Front Aging Neurosci. 2018 Jan 19;10:1. doi: 10.3389/fnagi.2018.00001. eCollection 2018. Front Aging Neurosci. 2018. PMID: 29403371 Free PMC article. Review.
References
-
- Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol. 2005;62:554–560. - PubMed
-
- Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson’s disease: an open-label randomised controlled trial. Lancet Neurol. 2012;11:140–149. - PubMed
-
- Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N Engl J Med. 2010;362:2077–2091. - PubMed
-
- Hariz MI, Rehncrona S, Quinn NP, Speelman JD, Wensing C, et al. Multicenter study on deep brain stimulation in Parkinson’s disease: an independent assessment of reported adverse events at 4 years. Mov Disord. 2008;23:416–421. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous